SE461041B - 4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-staellning, framstaellning daerav, anvaendning daerav som laekemedel samt farmaceutiska kompositioner innehaallande naemnda derivat - Google Patents

4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-staellning, framstaellning daerav, anvaendning daerav som laekemedel samt farmaceutiska kompositioner innehaallande naemnda derivat

Info

Publication number
SE461041B
SE461041B SE8302474A SE8302474A SE461041B SE 461041 B SE461041 B SE 461041B SE 8302474 A SE8302474 A SE 8302474A SE 8302474 A SE8302474 A SE 8302474A SE 461041 B SE461041 B SE 461041B
Authority
SE
Sweden
Prior art keywords
formula
carbon atoms
compound
hydrogen atom
alkyl group
Prior art date
Application number
SE8302474A
Other languages
English (en)
Swedish (sv)
Other versions
SE8302474L (sv
SE8302474D0 (sv
Inventor
F Clemence
O L Martret
F Delevallee
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SE8302474D0 publication Critical patent/SE8302474D0/xx
Publication of SE8302474L publication Critical patent/SE8302474L/xx
Publication of SE461041B publication Critical patent/SE461041B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Quinoline Compounds (AREA)
SE8302474A 1982-06-03 1983-05-02 4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-staellning, framstaellning daerav, anvaendning daerav som laekemedel samt farmaceutiska kompositioner innehaallande naemnda derivat SE461041B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8209654A FR2530633A1 (fr) 1982-06-03 1982-06-03 Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur preparation, leur application comme medicament, et les compositions les renfermant

Publications (3)

Publication Number Publication Date
SE8302474D0 SE8302474D0 (sv) 1983-05-02
SE8302474L SE8302474L (sv) 1983-12-04
SE461041B true SE461041B (sv) 1989-12-18

Family

ID=9274589

Family Applications (2)

Application Number Title Priority Date Filing Date
SE8302474A SE461041B (sv) 1982-06-03 1983-05-02 4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-staellning, framstaellning daerav, anvaendning daerav som laekemedel samt farmaceutiska kompositioner innehaallande naemnda derivat
SE8703886A SE466656B (sv) 1982-06-03 1987-10-08 Nya mellanprodukter anvaendbara foer framstaellning av 4-hydroxi-3-kinolinkarboxylsyraderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE8703886A SE466656B (sv) 1982-06-03 1987-10-08 Nya mellanprodukter anvaendbara foer framstaellning av 4-hydroxi-3-kinolinkarboxylsyraderivat

Country Status (13)

Country Link
US (3) US4486438A (de)
JP (1) JPS58225066A (de)
AT (1) AT385034B (de)
BE (1) BE896941A (de)
CA (1) CA1204116A (de)
CH (2) CH659818A5 (de)
DE (1) DE3320102A1 (de)
FR (1) FR2530633A1 (de)
GB (1) GB2123817B (de)
IT (1) IT1174760B (de)
LU (1) LU84841A1 (de)
NL (1) NL8301963A (de)
SE (2) SE461041B (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2553769B1 (fr) * 1983-10-20 1986-03-14 Roussel Uclaf Nouveau procede de preparation de derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2
FR2564835B1 (fr) * 1984-05-23 1986-10-24 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par un groupement soufre, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
FR2566405B1 (fr) * 1984-06-25 1986-09-26 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2 par une fonction aminee, leur preparation, leur application comme medicaments, les compositions les renfermant et les intermediaires nouveaux obtenus
US4845105A (en) * 1984-10-30 1989-07-04 Roussel Uclaf 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
FR2585356B1 (fr) * 1985-07-25 1987-10-23 Roussel Uclaf Nouveaux derives de l'acide 4-oh quinoleine carboxylique substitues en 2 par deux fonctions hydroxyle eventuellement etherifiees ou esterifiees, leurs procedes de preparation, les nouveaux intermediaires obtenus, leur application comme medicaments et les compositions les renfermant
FR2572404B2 (fr) * 1984-10-30 1987-12-11 Roussel Uclaf Nouveaux derives de l'acide 4-oh-3-quinoleine carboxylique substitues en 2, leur procede de preparation, leur application comme medicaments et les compositions les renfermant
US5166348A (en) * 1989-12-04 1992-11-24 Uralsky Politekhnichesky Institut Bornyl and isobornyl esters of carboxylic acids of condensed tetrahydroquinoxalines
TW200716611A (en) * 2005-04-29 2007-05-01 Wyeth Corp Process for preparing isatins with control of side-product formation
AU2014212426B8 (en) 2013-01-31 2018-05-10 Vertex Pharmaceuticals Incorporated Quinoline and Quinoxaline Amides as Modulators of Sodium Channels

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB610619A (en) * 1945-05-17 1948-10-19 Rhone Poulenc Sa Process for the separation of isomeric substituted quinoline carboxylic acids and esters thereof
GB1007331A (en) * 1960-12-01 1965-10-13 Fisons Pest Control Ltd Quinazolin-3-oxides and benzo-1,2,3-triazine-3-oxides
US3491138A (en) * 1964-06-26 1970-01-20 American Home Prod Benzodiazepine intermediates
FR2340735A1 (fr) * 1976-02-11 1977-09-09 Roussel Uclaf Nouveaux derives de l'acide 3-quinoleine carboxylique, leur procede de preparation et leur application comme medicament
FR2482596A1 (fr) * 1980-05-19 1981-11-20 Roussel Uclaf Nouveaux derives de l'acide 4-hydroxy 3-quinoleine carboxylique substitues en 2, leur procede de preparation et leur application comme medicament

Also Published As

Publication number Publication date
SE8703886L (sv) 1987-10-08
NL8301963A (nl) 1984-01-02
CA1204116A (fr) 1986-05-06
DE3320102C2 (de) 1992-07-02
GB8315132D0 (en) 1983-07-06
JPS58225066A (ja) 1983-12-27
FR2530633A1 (fr) 1984-01-27
CH659469A5 (fr) 1987-01-30
GB2123817B (en) 1985-09-04
CH659818A5 (fr) 1987-02-27
SE8703886D0 (sv) 1987-10-08
US4596875A (en) 1986-06-24
LU84841A1 (fr) 1984-03-07
SE8302474L (sv) 1983-12-04
AT385034B (de) 1988-02-10
IT1174760B (it) 1987-07-01
SE466656B (sv) 1992-03-16
US4486438A (en) 1984-12-04
JPH0354658B2 (de) 1991-08-20
ATA204083A (de) 1987-07-15
SE8302474D0 (sv) 1983-05-02
FR2530633B1 (de) 1984-12-28
GB2123817A (en) 1984-02-08
BE896941A (fr) 1983-12-02
DE3320102A1 (de) 1983-12-08
US4736033A (en) 1988-04-05

Similar Documents

Publication Publication Date Title
KR900007780B1 (ko) 축합된 피롤리논 유도체의 제조방법
CA2104883A1 (fr) Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant
JPS59148759A (ja) 新規なω−メルカプトプロパンアミドおよびその同族体の誘導体，該誘導体の製造方法，その，薬剤としての用途，該薬剤を含む組成物並びに取得される新規な中間体
DK148280B (da) Analogifremgangsmaade til fremstilling af thienothiazinderivater
US4299831A (en) 2-Trifluoromethyl-3-quinoline carboxamides, analgesic and anti-inflammatory compositions and methods employing them
DE69125308T2 (de) Indolderivate
EP0172096A1 (de) 3-Acylaminomethylimidazo [1,2-a] pyridine, dessen Herstellung und therapeutische Anwendung
SE461041B (sv) 4-hydroxi-3-kinolein-karboxylsyraderivat, substituerade i 2-staellning, framstaellning daerav, anvaendning daerav som laekemedel samt farmaceutiska kompositioner innehaallande naemnda derivat
JPS6340430B2 (de)
DK169383B1 (da) Lægemidler indeholdende 2-aminobenzothiazolforbindelser, 2-amino-benzothiazolforbindelser, fremgangsmåder til deres fremstilling og anvendelse af 2-aminobenzothiazolforbindelser til fremstilling af lægemidler.
US4845105A (en) 4-OH-quinoline carboxylic acid amides having analgesic and anti-inflammatory activity
DK172034B1 (da) 4-OH-quinolincarboxylsyrederivater, deres fremstilling, mellemprodukter ved deres fremstilling samt lægemidler med indhold deraf
JPH07252260A (ja) 新規チエノチアジン誘導体、その製造方法及びその使用方法
JPH064628B2 (ja) ２位置がアミノ官能基で置換された４―ヒドロキシ―３―キノリンカルボン酸の新誘導体、それらの製造、薬剤としての使用
US4735951A (en) Novel 4-hydroxy-3-quinoline-carboxylates having analgesic and anti-inflammatory activity
JPS61236774A (ja) ジベンズ［ｂｅ］オキセピン酢酸誘導体、その製造方法およびその治療への応用
FI68231C (fi) Analogifoerfarande foer framstaellning av nya terapeutiskt verkande bensimidazol-2-derivat
JPH0717647B2 (ja) テトラヒドロピリジン誘導体
FI70574B (fi) Foerfarande foer framstaellning av nya farmaceutiskt anvaendbara derivat av 2-((4-kinolinyl)-amino)-5-fluor- bensoesyra
EP0011854A1 (de) 4-(2'-Pyridylamino)phenylessigsäure-Derivate, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende pharmazeutische Mittel und ihre Verwendung
FR2593180A1 (fr) Derives d'acylaminomethyl-1 imidazo (1,2-a)quinoleines, leur preparation et leur application en therapeutique
NO854982L (no) Fremgangsmaate for fremstilling av optiske isomerer av tiazolo(3,2-a)-pyrimidiner, de fremstilte nye isomerer, farmasoeytiske komposisjoner inneholdene disse og mellomprodukter for gjennomfoering av fremgangsmaaten.
JPS6399069A (ja) 縮合イミダゾピリジン誘導体
JPS6019912B2 (ja) ２−アザエリスリナン誘導体
HRP920569A2 (en) Novel compounds, pharmaceutical compositions containing them and the process for preparing the same

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8302474-5

Effective date: 19941210

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8302474-5

Format of ref document f/p: F